TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
RGC

Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

7.20$ +6.2% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Regencell Bioscience Holdings Ltd (RGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 3.0 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RGC
Line item Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q3 25 Q4 25 Q1 26
2,676 2,554 2,540 2,484 2,591 2,409 2,632 2,591 2,573 2,478 2,646 2,686 2,748 2,672 2,843 – – 0.5 0.5 0.6 0.6 0.3 0.3 21 21 18 18 18 16 0.0 13 10 10 8.4 8.4 7.5 7.5 5.8 3.0 3.0
487 363 341 307 401 212 438 426 397 283 447 514 387 319 463 0.2 0.2 0.4 0.4 0.3 0.3 0.1 0.1 19 19 16 16 0.0 14 0.0 12 9.8 9.8 8.1 8.1 6.6 6.6 4.9 2.4 2.4
355 244 147 172 268 100 220 328 288 187 247 409 236 190 229 -0.2 -0.2 0.4 0.4 0.3 0.3 0.1 0.1 0.1 – 6.4 6.4 6.4 – 0.0 1.6 4.8 4.8 3.0 3.0 3.0 – 2.4 – 2.4
359 247 151 172 268 100 220 328 288 187 247 409 236 190 229 0.2 0.2 0.4 0.4 0.3 0.3 0.1 0.1 0.1 – 16 16 16 – 0.0 12 4.8 4.8 8.0 8.0 8.0 – 4.9 – 2.4
– – – 49 72 49 153 47 56 45 155 53 95 73 184 – – – – – – – 0.0 0.0 – – – 0.0 – – 0.1 0.1 – – 0.2 0.2 – – – –
18 17 18 18 19 20 22 23 23 21 21 23 24 24 23 – – – – – – – 0.0 0.0 – – 0.0 0.0 – – -0.1 -0.1 – – – -0.2 – – – –
– – – – – – – – – – – – – – – – – – – 0.1 0.1 0.1 0.1 – – 1.5 1.5 – – – – – – – – – – – – –
320 320 320 320 320 329 329 329 329 329 327 327 354 346 346 – – – – – – – – – – – – – – – – – – – – – – – – –
56 55 54 53 52 51 50 49 48 47 46 45 47 45 44 – – – – – – – – – – – – – – – – – – – – – – – – –
3,424 3,306 3,434 3,396 3,482 3,311 3,510 3,465 3,445 3,339 3,485 3,512 3,583 3,527 3,699 – – 3.2 3.2 3.6 3.6 4.3 4.3 1.4 1.4 0.9 0.9 0.9 0.9 0.0 0.6 0.3 0.3 0.2 0.2 0.8 0.8 0.9 1.8 1.8
460 357 477 426 508 346 551 509 483 372 510 522 435 378 561 – – 3.2 3.2 3.6 3.6 4.3 4.3 1.4 0.0 0.6 0.6 0.6 – 0.0 0.6 0.6 – 0.2 0.2 0.2 – 0.7 – 1.7
30 29 27 27 27 27 27 26 26 25 26 25 27 27 27 – – 3.1 3.1 3.5 3.5 3.7 3.7 1.4 0.0 0.4 0.4 0.4 – 0.4 0.4 0.4 – 0.1 0.1 0.1 – 0.3 – 0.3
162 108 166 119 200 102 230 167 184 102 195 177 122 122 232 – – – – – – – – – – – – – – – – – – – – – – – – –
-748 -753 -895 -909 -891 -902 -878 -874 -872 -862 -839 -826 -835 -855 -856 -1.8 -1.8 -2.7 -2.7 -3.0 -3.0 -4.0 -4.0 20 20 17 17 0.0 15 0.0 12 10 10 8.2 8.2 6.7 6.7 4.9 1.2 1.2
40 32 48 37 56 44 64 70 70 77 97 110 99 76 71 – – -2.7 -2.7 -3.0 -3.0 -4.0 -4.0 -4.0 – -11 -11 -11 – 0.0 -17 -17 – -22 -22 -22 – -25 – -31
5,935 5,938 5,940 5,951 5,946 5,947 5,951 5,958 5,958 5,962 5,966 5,967 5,967 5,967 5,967 380 380 380 380 380 380 380 380 478 493 495 494 13 494 13 494 494 494 494 494 494 494 494 494 494

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?